326 results on '"Imamura, Yoshinori"'
Search Results
2. Prognostic impact of concomitant pH-regulating drugs in patients with non-small cell lung cancer receiving epidermal growth factor receptor tyrosine kinase inhibitors: the Tokushukai REAl-world Data project 01-S1
3. Comparison of antimicrobial therapy termination in febrile and afebrile patients with acute cholangitis after drainage
4. Risk prediction model for cisplatin-induced acute kidney injury in patients with head and neck cancer receiving chemoradiotherapy: A re-analysis of a phase II/III JCOG1008 trial
5. Phase I trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF-CRT) for locally advanced squamous cell carcinoma of the external auditory canal
6. Apixaban in Japanese patients with cancer-associated venous thromboembolism: a multi-center phase II trial
7. Safety and immunogenicity of the COVID-19 vaccine BNT162b2 in patients undergoing chemotherapy for solid cancer
8. Different characteristics of the tumor immune microenvironment among subtypes of salivary gland cancer.
9. Limited increase in antibody titers following mRNA SARS-CoV-2 vaccination for more than 3 years after final dose of anti-CD20 antibody
10. Analysis of B‐cell receptor repertoire to evaluate immunogenicity of monovalent Omicron XBB.1.5 mRNA vaccines
11. Surgical outcomes of metastatic bone tumors in the extremities (Surgical outcomes of bone metastases)
12. Incidence of venous thromboembolism in patients with solid cancers in Japan: retrospective study of 2735 patients
13. Effect of acute kidney injury and overall survival in patients with postoperative head and neck cancer who received chemoradiotherapy with cisplatin: A supplementary analysis of the phase II/III trial of JCOG1008.
14. Antimicrobial therapy outcomes in acute cholangitis: Hilar multiple obstructions versus single hilar and common bile duct obstructions
15. Association of short-course antimicrobial therapy and bacterial resistance in acute cholangitis: Retrospective cohort study
16. Inflammation‑based prognostic markers of metastatic pancreatic cancer using real‑world data in Japan: The Tokushukai REAl‑world Data (TREAD) project
17. Phase 1 study of Gemcitabine/Nab-paclitaxel/S-1 in patients with unresectable pancreatic cancer (GeNeS1S trial)
18. Docetaxel plus cisplatin in recurrent and/or metastatic non-squamous-cell head and neck cancer: a multicenter phase II trial
19. Stepwise prolongation of overall survival from first to third generation EGFR-TKIs for EGFR mutation-positive non-small-cell lung cancer: the Tokushukai REAl-world Data project (TREAD 01)
20. MO28-6 Feasibility of the online-based QOL survey in patients with head and neck cancer. A multi-center, prospective study
21. P10-2 Prognostic value of systemic inflammation in patients undergoing 1st-line chemotherapy for metastatic pancreatic cancer: Tokushukai REAl-world Data project
22. P57-1 Real-world treatment outcomes of metastatic biliary tract cancer in Japan: Tokushukai REAl-world Data project; TREAD 04
23. P25-3 Prognostic impact of concomitant antacids in EGFR-mutation-positive NSCLC: The Tokushukai REAl-world Data project (TREAD 01-S2)
24. Stepwise prolongation of overall survival from first- to third-generation EGFR-tyrosine kinase inhibitors in non-small cell lung cancer and the prognostic impact of concomitant antacids.
25. P10-1 Analysis of thromboembolism and prognosis in metastatic pancreatic cancer: A secondary analysis of Tokushukai REAl-world Data project 03-S1
26. Adipose-derived stem cells enhance human breast cancer growth and cancer stem cell-like properties through adipsin
27. Expression of preference for the disclosure of secondary findings of comprehensive genomic profiling tests by cancer patients and relatives
28. Ibuprofen gargle for chemo- or Chemoradiotherapy-induced Oral Mucositis: a feasibility study
29. Stepwise prolongation of overall survival from first to third generation EGFR-TKIs for EGFR mutation-positive non-small-cell lung cancer: the Tokushukai REAl-world Data project (TREAD 01).
30. Real-world treatment outcomes of metastatic biliary tract cancer patients in Japan: the Tokushukai REAl-world data project 04 (TREAD 04).
31. A phase II trial of nivolumab for patients with platinum-refractory recurrent or metastatic salivary gland cancer.
32. Microsatellite instability-high colorectal cancer patient-derived xenograft models for cancer immunity research
33. Immunosuppressive effects and mechanisms of three myeloid-derived suppressor cells subsets including monocytic-myeloid-derived suppressor cells, granulocytic-myeloid-derived suppressor cells, and immature-myeloid-derived suppressor cells
34. Device-related Mycobacterium mageritense Infection in a Patient Treated with Nivolumab for Metastatic Breast Cancer
35. Real-World Outcomes of Systemic Therapy in Japanese Patients with Cancer (Tokushukai REAl-World Data Project: TREAD): Study Protocol for a Nationwide Cohort Study
36. Response to mRNA SARS‐CoV‐2 vaccination evaluated by B‐cell receptor repertoire after tixagevimab/cilgavimab administration.
37. A prospective study of the antiemetic effect of palonosetron in malignant lymphoma patients treated with the CHOP regimen
38. The combination of HLA-B*15:01 and DRB1*15:01 is associated with gemcitabine plus erlotinib-induced interstitial lung disease in patients with advanced pancreatic cancer
39. Validity of new methods to evaluate renal function in cancer patients treated with cisplatin
40. MO6-1 Real-world treatment outcomes of metastatic pancreatic cancer in Japan: Tokushukai REAl-world Data project 03 (TREAD 03)
41. MO8-3 Real-world outcomes of systemic therapy in Japanese cancer patients: Tokushukai REAl-world Data project (TREAD)
42. P57-7 Inflammatory scores in gastric cancer patients treated with nivolumab: Tokushukai REAl-world Data project 02 (TREAD 02)
43. Promising Efficacy of a Third Dose of mRNA SARS-CoV-2 Vaccination in Patients Treated with Anti-CD20 Antibody Who Failed 2-Dose Vaccination
44. Abstract 6143: Tumor immune microenvironment in salivary gland cancer
45. Promising efficacy of following a third dose of mRNA SARS-CoV-2 vaccination in patients treated with anti-CD20 antibody who failed 2-dose vaccination
46. Transition of the PD‑1 occupancy of nivolumab on T cells after discontinuation and response of nivolumab re‑challenge
47. Human papillomavirus-related oropharyngeal carcinoma
48. Identification of Breast Cancer Stem Cells Using a Newly Developed Long-acting Fluorescence Probe, C5S-A, Targeting ALDH1A1
49. Systemic therapy for salivary gland malignancy: current status and future perspectives
50. P1-006 - Remarkable response to cetuximab-containing chemotherapy for tongue cancer refractory to immune checkpoint inhibitors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.